KEVIN ZENT: Open Payments
NPI 1255380648 · SOMERSWORTH, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 48 payments from 15 companies in 2025. Trend: 2023 $671 · 2024 $642 · 2025 $772
Food & beverage: $772
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $242 |
| Axsome Therapeutics, Inc. | 7 | $145 |
| Gilead Sciences, Inc. | 5 | $111 |
| Baxter Healthcare | 1 | $61 |
| PFIZER INC. | 2 | $33 |
| Hologic Sales and Service, LLC | 1 | $23 |
| Indivior Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: VRAYLAR, Auvelity, Hillrom - Carnation Ambulatory Monitor, MAVYRET, APTIMA, SUBLOCADE, CAPVAXIVE, TRUMENBA.
Industry payments across NH — which companies pay providers there.
